Browsing: Eli

Wednesday’s trading session is showcasing notable intra-day stock movements across various market cap categories, with UnitedHealth Group (UNH) and Eli…

By Bhanvi Satija and Patrick Wingrove (Reuters) -Sales of Eli Lilly (NYSE:)’s high profile weight-loss and diabetes drugs fell short…

Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines. The facility,…

Friday’s market has seen significant movements in a range of stocks, with some mega-cap and large-cap stocks experiencing notable intra-day…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…

(This Sept. 2 story has been corrected to remove Delta Corp which was erroneously included in the list in both…

Check out the companies making headlines in midday trading: Paramount Global — The media conglomerate’s stock dropped more than 5%…

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a…

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly…

(Reuters) -Eli Lilly’s treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service (NHS),…